Nutex Health Inc. reported $847M of revenue over the trailing twelve months, +6.9% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $847M (to Q2 2026). Net income: $180M, trailing twelve months to Q2 2026. Free cash flow: $274M, trailing twelve months to Q2 2026. Operating margin: 41%, trailing twelve months to Q2 2026.

NUTXNutex Health Inc.

Healthcare

$206.30+115% 1Y

$206.30

$87.0152 weeks$225.00

NUTX as reported

Nutex Health Inc. reported $847M of revenue over the trailing twelve months, +6.9% on the year before. 11 reported series are charted on this page, each one as filed.

$847M

Revenue, trailing twelve months · to Q2 2026 · +6.9% against the twelve months before

Net income: $180M
Net income · +219% year on year · trailing twelve months to Q2 2026
Free cash flow: $274M
Free cash flow · +229% year on year · trailing twelve months to Q2 2026
Operating margin: 41%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for NUTX, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$847M	+6.9%	Q2 2026
Net income	$180M	+219%	Q2 2026
EPS	$25.27	+158%	Q2 2026
Gross margin	49%	n/a	Q2 2026
Operating margin	41%	n/a	Q2 2026
Net margin	20%	n/a	Q2 2026
ROE	33%	n/a	Q2 2026
ROA	12%	n/a	Q2 2026
ROIC	126%	n/a	Q2 2026
Free cash flow	$274M	+229%	Q2 2026
P/E	8.16	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.